Comparative bioavailability of a cisapri
β
T. Hedner; J. Hedner; A. Gelin-Friberg; M. L. Huang; S. Poel; R. Woestenborghs;
π
Article
π
1990
π
Springer
π
English
β 300 KB
The comparative bioavailability of cisapride as a 30 mg suppository and three 5 mg oral tablets was investigated in 12 non-smoking, healthy male volunteers. The two formulations were administered on two separate occasions following an overnight fast, according to a randomized cross-over design. The